Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

New study of toxins and heart disease

Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Fusion between pharma giants?

It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Vattenfall is firing with biomass

Vattenfall will provide Denmark with electricity by means of biomass.

Hormones make children fat

A new Danish million project will define the connection between hormons and obesity amongst children.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

LEO Pharma - International Clinical Trial Manager

Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark